It works by activating three key hormone receptorsGLP-1, GIP, and glucagonthat help regulate appetite, energy balance, and fat metabolism
This dual action provides extra support for appetite control and energy use, making it especially helpful for individuals requiring broader metabolic support
10.1016/j.bbi.2009.05.058 158
Boire A, Brandsma D, Brastianos PK, Le Rhun E, Ahluwalia M, Junck L, et al
1 Oral semaglutide for type 2 diabetes has been available as Rybelsus in a different formulation and set of doses
Conflict of interest DK has received research support from Sanofi, Tanabe Pharma, Terumo, Behringer Ingelheim, Kyowa Kirin, Sumitomo Dainippon Pharma, Ono Pharmaceutical and Takeda Pharmaceutical as well as speaker honoraria from Novo Nordisk Pharma, Sanofi, and Takeda Pharmaceutical